ZA200802953B - Solid vaccine formulation - Google Patents

Solid vaccine formulation

Info

Publication number
ZA200802953B
ZA200802953B ZA200802953A ZA200802953A ZA200802953B ZA 200802953 B ZA200802953 B ZA 200802953B ZA 200802953 A ZA200802953 A ZA 200802953A ZA 200802953 A ZA200802953 A ZA 200802953A ZA 200802953 B ZA200802953 B ZA 200802953B
Authority
ZA
South Africa
Prior art keywords
vaccine formulation
solid vaccine
solid
formulation
vaccine
Prior art date
Application number
ZA200802953A
Inventor
Hejl Charlotte
Ipsen Hans-Henrik
Lundegaard Annette Roemmelmayer
Maerkedahl Lise Lund
Soenderkaer Susanne
Seppaelae Ulla
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of ZA200802953B publication Critical patent/ZA200802953B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
ZA200802953A 2005-10-04 2008-04-03 Solid vaccine formulation ZA200802953B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200501392 2005-10-04

Publications (1)

Publication Number Publication Date
ZA200802953B true ZA200802953B (en) 2009-01-28

Family

ID=35602348

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200802953A ZA200802953B (en) 2005-10-04 2008-04-03 Solid vaccine formulation

Country Status (3)

Country Link
CN (1) CN101296705A (en)
BR (1) BRPI0616879A2 (en)
ZA (1) ZA200802953B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2558120A4 (en) * 2010-04-15 2013-08-28 Shin Nippon Biomedical Lab Ltd Methods and compositions for intranasal delivery
JP6110845B2 (en) * 2011-05-17 2017-04-05 ザ リージェント オブ ザ ユニバーシティー オブ コロラド、ア ボディー コーポレート Heat resistant vaccine composition and method for preparing the same
WO2014100860A2 (en) * 2012-12-28 2014-07-03 Cellestis Limited A cell mediated immune response assay
WO2017090766A1 (en) * 2015-11-27 2017-06-01 日東電工株式会社 Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration
JP7339886B2 (en) * 2016-11-21 2023-09-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Liquid allergen composition and method for producing the same
JOP20200140A1 (en) 2017-12-07 2022-10-30 Merck Sharp & Dohme Formulations of dengue virus vaccine compositions

Also Published As

Publication number Publication date
BRPI0616879A2 (en) 2011-07-05
CN101296705A (en) 2008-10-29

Similar Documents

Publication Publication Date Title
ZA200708634B (en) Novel vaccine formulations
IL192084A0 (en) Vaccine
GB0504436D0 (en) Vaccine
GB0505909D0 (en) Formulations
IL186828A0 (en) Vaccine composition
EP1909584A4 (en) Prenylflavonoid formulations
GB0526419D0 (en) Formulation
GB0505569D0 (en) Formulations
GB0517673D0 (en) Formulation
ZA200802953B (en) Solid vaccine formulation
GB0515135D0 (en) Vaccine
GB0501030D0 (en) Formulation
GB0504940D0 (en) Vaccine formulation
ZA200709207B (en) Vaccine
LT1928232T (en) Solid formulation
GB0516944D0 (en) Vaccine
GB0810662D0 (en) Vaccine
ZA200709210B (en) Vaccine
GB0526412D0 (en) Vaccine
GB0502569D0 (en) Vaccine composition
GB0500807D0 (en) Formulation
GB0507811D0 (en) Formulation
GB0510788D0 (en) Formulation
GB0513194D0 (en) Vaccine
GB0526232D0 (en) Vaccine